Pfizer Announces Its Covid Vaccine Has 90 Percent Efficacy, Buoying Optimism

But wait, is it not yet time to throw away your mask or to fill party halls. Spokesperson says Brazil is in talks with Pfizer to buy COVID-19 vaccine.

RIO DE JANEIRO, BRAZIL - An announcement by Pfizer Monday that interim reports of its COVID-19 vaccine show a 90 percent efficacy made headlines around the world in a welcome break from grim news about the progress of the disease. The news boosted the DOW to a gain of nearly 1500 points by mid-morning Monday, November 9th. Indeed it is a remarkable level of effectiveness.

"Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?